Clinical predictors and time course of the improvement in β–cell function with short‐term intensive insulin therapy in patients with Type 2 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|32|5|645-652

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.5, 2015-05, pp. : 645-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 541-545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metformin and β‐cell function in insulin‐treated patients with type 2 diabetes: A randomized placebo‐controlled 4.3‐year trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 730-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 6, 2015-09 ,pp. : 537-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metformin and glargine in T2DM after IIT

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 182-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short-Term Effects of Improved Glycemic Control on Cognitive Function in Patients with Type 2 Diabetes

By  

Gerontology, Vol. 49, Iss. 2, 2003-02 ,pp. : 86-92

Karger

Access to resources Recommend Favorite